|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 18739593.4 (espacenet) (Federated) (European Patent Register), 20180628 | | Patent/reg. no. and date | DK/EP 3654989, 20240103 | | Publication date | 20200527 | | Priority no. and date | GB 201711800, 20170721 | | EP pub. no. and date |
EP 3654989 20200527 | | Effective date | | | Applicant/owner | Chord Therapeutics SA, c/o ARES TRADING SA
Terre Bonne Business Park
Route de Crassier 1
1262 Eysins, CH | | Applicant ref. no. | V472153DK00 | | Inventor | REJDAK, Konrad, Organowa 3/20
20-882 Lublin, PL | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/7076 (2006.01) , A61P 21/04 (2006.01) , A61P 37/06 (2006.01) | | Title | Anvendelse af cladribin til behandling af autoimmun neuromuskulær sygdom | | Int. application no. | GB2018051801 | | Int. publication no. | WO2019016505 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
